We demonstrated a significant increase in the content of CD14 + cells in the peripheral blood in patients with MS (8.9 (8.2-9.8) compared with the control group (4.8 (4.0-5.4)) (p < 0.05) (Figure 2). The gene discussed is CD14; the disease is myeloid sarcoma.